Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine the activity, to assess the safety and tolerance of
BKM120 in adult patients with recurrent or metastatic head and neck cancer progressive under
platin and cetuximab-based chemotherapy.